FOLLICULINUM, OOPHORINUM,

FOLLICULINUM, OOPHORINUM, was reported 3082 times

FOLLICULINUM, OOPHORINUM, is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAROTID PULSE INCREASED 2 0.1053
1 BIOPSY BREAST ABNORMAL 5 0.0526
2 MALIGNANT BREAST LUMP REMOVAL 6 0.0448
3 THYROTOXIC PERIODIC PARALYSIS 4 0.0274
4 BLOOD ALDOSTERONE DECREASED 2 0.0263
5 BREAST RECONSTRUCTION 9 0.0239
6 PERSISTENT GENITAL AROUSAL DISORDER 4 0.0172
7 BREAST MICROCALCIFICATION 2 0.0167
8 CERVIX NEOPLASM 2 0.0146
9 BREAST INJURY 2 0.0123
10 CARNITINE DEFICIENCY 2 0.0117
11 OESTROGEN DEFICIENCY 3 0.0109
12 VULVOVAGINITIS 3 0.0102
13 BREAST OPERATION 8 0.0098
14 BIOPSY BREAST 3 0.0096
15 MASTECTOMY 15 0.0086
16 CERVICAL POLYP 3 0.0079
17 HYPOPARATHYROIDISM 6 0.0078
18 BLOOD CORTISOL INCREASED 2 0.0075
19 BONE FRAGMENTATION 4 0.0071
20 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
21 ENDOMETRIAL HYPERPLASIA 5 0.0062
22 CALCIUM DEFICIENCY 8 0.0062
23 ADMINISTRATION SITE BRUISE 2 0.0058
24 TRI-IODOTHYRONINE DECREASED 3 0.0057
25 BREAST HYPERPLASIA 2 0.0057
26 FIBROCYSTIC BREAST DISEASE 4 0.0054
27 ENDOMETRIAL THICKENING 3 0.0054
28 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 2 0.0051
29 PREMATURE MENOPAUSE 4 0.0043
30 FOREARM FRACTURE 3 0.0043
31 CERVICAL RADICULOPATHY 3 0.0042
32 ATROPHIC VULVOVAGINITIS 3 0.0041
33 CAPILLARY FRAGILITY 2 0.0039
34 BREAST CONSERVING SURGERY 2 0.0039
35 MENOPAUSAL SYMPTOMS 9 0.0039
36 UTERINE DISORDER 9 0.0039
37 CATAPLEXY 5 0.0035
38 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
39 ADENOMYOSIS 2 0.0034
40 PALATAL OEDEMA 4 0.0032
41 AMPUTATION 4 0.0032
42 NARCOLEPSY 6 0.0032
43 PELVIC DISCOMFORT 3 0.0032
44 ENDOMETRIOSIS 15 0.0031
45 VAGINAL DISORDER 3 0.0031
46 ADNEXA UTERI PAIN 4 0.0031
47 ULNA FRACTURE 3 0.0030
48 SKIN OEDEMA 3 0.0030
49 BLOOD OESTROGEN DECREASED 2 0.0028
50 APPLICATION SITE ULCER 2 0.0028
51 VULVOVAGINAL DRYNESS 9 0.0028
52 CEREBRAL VASOCONSTRICTION 2 0.0027
53 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
54 INAPPROPRIATE AFFECT 4 0.0025
55 BREAST CALCIFICATIONS 2 0.0025
56 NIGHT BLINDNESS 4 0.0025
57 BLADDER PROLAPSE 3 0.0025
58 LIMB MASS 5 0.0023
59 HORMONE LEVEL ABNORMAL 11 0.0023
60 TRICHORRHEXIS 6 0.0021
61 BREAST ENLARGEMENT 7 0.0021
62 ATYPICAL FEMUR FRACTURE 6 0.0021
63 CONNECTIVE TISSUE DISORDER 3 0.0021
64 HAIR DISORDER 17 0.0021
65 APPLICATION SITE BRUISE 2 0.0021
66 ANIMAL SCRATCH 2 0.0021
67 EARLY SATIETY 4 0.0021
68 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
69 ADHESION 3 0.0020
70 POSTMENOPAUSAL HAEMORRHAGE 5 0.0019
71 LIMB DEFORMITY 3 0.0019
72 BONE NEOPLASM 2 0.0019
73 PITUITARY TUMOUR BENIGN 3 0.0018
74 INVASIVE DUCTAL BREAST CARCINOMA 5 0.0018
75 VULVOVAGINAL DISCOMFORT 8 0.0018
76 MADAROSIS 21 0.0018
77 AORTIC DILATATION 2 0.0018
78 VITAMIN B12 DEFICIENCY 7 0.0017
79 HAIR TEXTURE ABNORMAL 23 0.0017
80 APPENDICECTOMY 6 0.0017
81 UTERINE POLYP 3 0.0017
82 LONG QT SYNDROME 4 0.0017
83 RADIUS FRACTURE 4 0.0017
84 UTERINE HAEMORRHAGE 7 0.0016
85 VULVOVAGINAL SWELLING 3 0.0016
86 UTERINE SPASM 3 0.0016
87 PSYCHOLOGICAL TRAUMA 14 0.0016
88 CARTILAGE INJURY 4 0.0016
89 HYSTERECTOMY 14 0.0016
90 APPLICATION SITE SCAR 2 0.0016
91 HAIR GROWTH ABNORMAL 11 0.0016
92 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
93 PANCREATIC CYST 3 0.0016
94 GINGIVAL RECESSION 3 0.0016
95 DRUG TITRATION ERROR 4 0.0015
96 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
97 NIPPLE PAIN 3 0.0015
98 CARBON DIOXIDE INCREASED 2 0.0015
99 APPLICATION SITE INFLAMMATION 2 0.0014
100 PRE-EXISTING CONDITION IMPROVED 9 0.0014
101 VULVOVAGINAL PRURITUS 7 0.0014
102 SPINAL OSTEOARTHRITIS 12 0.0014
103 MIDDLE EAR EFFUSION 3 0.0014
104 LIGAMENT RUPTURE 6 0.0014
105 SPINAL COLUMN INJURY 3 0.0013
106 AUTOIMMUNE THYROIDITIS 5 0.0013
107 VULVOVAGINAL BURNING SENSATION 8 0.0013
108 DYSPAREUNIA 6 0.0013
109 SCOLIOSIS 8 0.0013
110 HAIR COLOUR CHANGES 16 0.0013
111 NAIL DISCOLOURATION 5 0.0013
112 OSTEOPENIA 19 0.0013
113 HOMICIDAL IDEATION 5 0.0012
114 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
115 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
116 APPLICATION SITE SWELLING 6 0.0012
117 EYELID IRRITATION 3 0.0012
118 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
119 CERVICAL SPINAL STENOSIS 2 0.0012
120 BREAST CANCER FEMALE 31 0.0012
121 LYMPHOEDEMA 8 0.0012
122 TACHYPHRENIA 4 0.0012
123 BONE DISORDER 21 0.0012
124 ERYTHEMA NODOSUM 4 0.0011
125 FACIAL PARESIS 4 0.0011
126 VITAMIN D DEFICIENCY 11 0.0011
127 FIBRIN D DIMER INCREASED 4 0.0011
128 CARDIAC ABLATION 2 0.0011
129 UTERINE LEIOMYOMA 8 0.0011
130 PARADOXICAL DRUG REACTION 4 0.0011
131 TENDON INJURY 4 0.0011
132 AURA 2 0.0011
133 PRODUCT FORMULATION ISSUE 7 0.0011
134 FIBULA FRACTURE 3 0.0010
135 GINGIVAL DISORDER 4 0.0010
136 HYPERTONIC BLADDER 3 0.0010
137 ATROPHY 2 0.0010
138 EPIGASTRIC DISCOMFORT 4 0.0010
139 FOOT OPERATION 5 0.0010
140 CANDIDIASIS 4 0.0010
141 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
142 VAGINAL DISCHARGE 10 0.0010
143 BREAST DISORDER 2 0.0010
144 INTRACARDIAC THROMBUS 3 0.0010
145 CHEST INJURY 2 0.0010
146 THYROID FUNCTION TEST ABNORMAL 4 0.0010
147 NASAL DRYNESS 6 0.0010
148 BLOOD TESTOSTERONE INCREASED 2 0.0009
149 APPLICATION SITE SCAB 2 0.0009
150 LYMPHOCYTE COUNT INCREASED 3 0.0009
151 WRIST FRACTURE 11 0.0009
152 CERVICAL DYSPLASIA 2 0.0009
153 HOT FLUSH 69 0.0009
154 MULTIPLE FRACTURES 15 0.0009
155 GASTROINTESTINAL PAIN 10 0.0009
156 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
157 THERAPEUTIC AGENT TOXICITY 3 0.0009
158 APPLICATION SITE URTICARIA 2 0.0009
159 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
160 EYELID PTOSIS 9 0.0009
161 NASAL DISCOMFORT 7 0.0009
162 SKIN ATROPHY 5 0.0009
163 FEELING OF DESPAIR 4 0.0009
164 DRUG ADMINISTERED AT INAPPROPRIATE SITE 9 0.0009
165 WRONG TECHNIQUE IN DRUG USAGE PROCESS 31 0.0009
166 OSTEOPOROSIS 35 0.0009
167 LACERATION 8 0.0008
168 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
169 PHARYNGEAL OEDEMA 13 0.0008
170 FOOT FRACTURE 16 0.0008
171 EMBOLISM 7 0.0008
172 BODY HEIGHT DECREASED 9 0.0008
173 ANKLE FRACTURE 13 0.0008
174 VULVOVAGINAL PAIN 4 0.0008
175 BRONCHITIS CHRONIC 2 0.0008
176 VITREOUS FLOATERS 8 0.0008
177 MENISCUS INJURY 5 0.0008
178 OVARIAN CYST 8 0.0008
179 VEIN DISORDER 4 0.0008
180 PAROSMIA 6 0.0008
181 PARANASAL SINUS DISCOMFORT 3 0.0008
182 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
183 FEELING JITTERY 15 0.0008
184 PARANASAL SINUS HYPERSECRETION 3 0.0008
185 FIBROMYALGIA 19 0.0008
186 AORTIC ARTERIOSCLEROSIS 2 0.0008
187 TENDONITIS 12 0.0008
188 CONCUSSION 6 0.0008
189 CARDIAC FLUTTER 5 0.0008
190 RESTLESS LEGS SYNDROME 14 0.0008
191 EXOSTOSIS 7 0.0008
192 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
193 SOMNAMBULISM 5 0.0008
194 CYSTITIS 24 0.0008
195 FOREIGN BODY 3 0.0007
196 ALCOHOL ABUSE 2 0.0007
197 ABDOMINAL MASS 2 0.0007
198 COLITIS ISCHAEMIC 5 0.0007
199 ERYTHEMA OF EYELID 4 0.0007
200 CHONDROPATHY 2 0.0007
201 TRIGGER FINGER 3 0.0007
202 GOITRE 3 0.0007
203 SPINAL STENOSIS 3 0.0007
204 PELVIC PAIN 13 0.0007
205 ANGIOPATHY 4 0.0007
206 SLEEP TERROR 3 0.0007
207 APPLICATION SITE REACTION 5 0.0007
208 AORTIC VALVE INCOMPETENCE 3 0.0007
209 ROTATOR CUFF SYNDROME 9 0.0007
210 CHOLECYSTECTOMY 8 0.0007
211 CARDIAC VALVE DISEASE 4 0.0007
212 PARALYSIS 10 0.0007
213 TENSION HEADACHE 3 0.0007
214 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
215 HYPERTHYROIDISM 10 0.0007
216 DRY THROAT 7 0.0007
217 BILIARY COLIC 2 0.0007
218 TONGUE DISCOLOURATION 3 0.0007
219 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
220 PURPURA 6 0.0007
221 ENERGY INCREASED 4 0.0007
222 PSYCHIATRIC SYMPTOM 5 0.0007
223 BREAST TENDERNESS 5 0.0007
224 ECONOMIC PROBLEM 10 0.0007
225 INJECTION SITE PAPULE 3 0.0007
226 POOR QUALITY SLEEP 14 0.0006
227 THYROID DISORDER 10 0.0006
228 PIGMENTATION DISORDER 4 0.0006
229 NEPHROGENIC ANAEMIA 3 0.0006
230 SCAR 11 0.0006
231 DRY EYE 32 0.0006
232 MUSCULOSKELETAL DISCOMFORT 11 0.0006
233 VAGINAL INFECTION 3 0.0006
234 OSTEOARTHRITIS 27 0.0006
235 AFFECTIVE DISORDER 5 0.0006
236 SKIN ABRASION 3 0.0006
237 SPINAL DISORDER 6 0.0006
238 ABDOMINAL ADHESIONS 2 0.0006
239 CRYING 23 0.0006
240 MUSCLE ATROPHY 8 0.0006
241 NERVE INJURY 7 0.0006
242 FOREIGN BODY SENSATION IN EYES 4 0.0006
243 RASH PAPULAR 14 0.0006
244 FAECAL INCONTINENCE 3 0.0006
245 INTENTIONAL DRUG MISUSE 13 0.0006
246 ERUCTATION 12 0.0006
247 APPLICATION SITE VESICLES 4 0.0006
248 GALLBLADDER DISORDER 11 0.0006
249 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
250 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
251 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
252 TENDON DISORDER 4 0.0006
253 COELIAC DISEASE 6 0.0006
254 ARTHRITIS 48 0.0006
255 TOOTHACHE 11 0.0006
256 INFLAMMATORY MARKER INCREASED 3 0.0006
257 SPINAL COMPRESSION FRACTURE 5 0.0006
258 ABDOMINAL TENDERNESS 3 0.0006
259 EYELID OEDEMA 7 0.0006
260 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
261 HYPOTHYROIDISM 19 0.0006
262 DRUG TOLERANCE 3 0.0006
263 POSTOPERATIVE WOUND INFECTION 4 0.0006
264 APPLICATION SITE PAIN 13 0.0006
265 TINNITUS 27 0.0006
266 ABNORMAL LOSS OF WEIGHT 4 0.0006
267 FEMORAL NECK FRACTURE 3 0.0006
268 VITAMIN D DECREASED 5 0.0006
269 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
270 PERIPHERAL VASCULAR DISORDER 3 0.0006
271 CERVICAL VERTEBRAL FRACTURE 2 0.0006
272 BREAST CANCER 54 0.0006
273 VAGINAL HAEMORRHAGE 25 0.0006
274 HYPOMAGNESAEMIA 8 0.0006
275 MALABSORPTION 3 0.0006
276 AORTIC STENOSIS 2 0.0006
277 CAROTID ARTERY STENOSIS 2 0.0006
278 TENDON RUPTURE 7 0.0006
279 ANORECTAL DISCOMFORT 3 0.0006
280 THERMAL BURN 4 0.0006
281 RESPIRATORY RATE INCREASED 5 0.0006
282 JOINT INJURY 12 0.0006
283 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
284 NIGHT SWEATS 18 0.0006
285 IMPAIRED QUALITY OF LIFE 8 0.0006
286 GINGIVITIS 3 0.0006
287 ANAL INCONTINENCE 5 0.0006
288 PARAESTHESIA ORAL 8 0.0006
289 BONE LESION 2 0.0006
290 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
291 TONGUE DISORDER 4 0.0006
292 SKIN LACERATION 6 0.0006
293 JAW DISORDER 3 0.0005
294 INJECTION SITE NODULE 6 0.0005
295 ALOPECIA 106 0.0005
296 FEELING COLD 15 0.0005
297 NECK PAIN 30 0.0005
298 NERVOUSNESS 28 0.0005
299 MIDDLE INSOMNIA 10 0.0005
300 BONE DENSITY ABNORMAL 2 0.0005
301 MIGRAINE 51 0.0005
302 FLANK PAIN 5 0.0005
303 EYE INFECTION 6 0.0005
304 SQUAMOUS CELL CARCINOMA 5 0.0005
305 ANKYLOSING SPONDYLITIS 7 0.0005
306 HYPERHIDROSIS 68 0.0005
307 CLAVICLE FRACTURE 2 0.0005
308 HYPERVENTILATION 3 0.0005
309 BLOOD CHOLESTEROL INCREASED 24 0.0005
310 IMPAIRED WORK ABILITY 11 0.0005
311 SPLENOMEGALY 6 0.0005
312 GASTROINTESTINAL INFLAMMATION 4 0.0005
313 TORSADE DE POINTES 4 0.0005
314 PERIPHERAL COLDNESS 7 0.0005
315 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
316 APPLICATION SITE RASH 7 0.0005
317 LYMPHADENOPATHY 18 0.0005
318 ABNORMAL DREAMS 14 0.0005
319 SINUS HEADACHE 3 0.0005
320 CHOLECYSTITIS 6 0.0005
321 UPPER LIMB FRACTURE 10 0.0005
322 COORDINATION ABNORMAL 7 0.0005
323 CEREBRAL ATROPHY 2 0.0005
324 APHONIA 7 0.0005
325 ARTERIOSPASM CORONARY 2 0.0005
326 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
327 MUSCULOSKELETAL PAIN 26 0.0005
328 RHINITIS 4 0.0005
329 APPLICATION SITE ERYTHEMA 13 0.0005
330 INJECTION SITE VESICLES 3 0.0005
331 BURSITIS 6 0.0005
332 PAIN IN JAW 14 0.0005
333 FEELING HOT 30 0.0005
334 FEELING ABNORMAL 117 0.0005
335 EUPHORIC MOOD 5 0.0005
336 EAR DISCOMFORT 5 0.0005
337 HYPERAESTHESIA 4 0.0005
338 EMOTIONAL DISORDER 15 0.0005
339 APPLICATION SITE EXFOLIATION 2 0.0005
340 INSOMNIA 129 0.0005
341 CYST 6 0.0005
342 FEAR 13 0.0005
343 THINKING ABNORMAL 9 0.0005
344 EYE DISCHARGE 5 0.0005
345 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
346 TENDERNESS 5 0.0005
347 SECRETION DISCHARGE 6 0.0005
348 PALPITATIONS 56 0.0005
349 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
350 PRODUCT ODOUR ABNORMAL 5 0.0005
351 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
352 PHOTOPSIA 3 0.0005
353 JOINT DISLOCATION 5 0.0005
354 URINARY INCONTINENCE 14 0.0005
355 MOOD SWINGS 15 0.0005
356 BREAST PAIN 5 0.0005
357 IRRITABLE BOWEL SYNDROME 10 0.0005
358 HEREDITARY ANGIOEDEMA 5 0.0005
359 ABNORMAL SENSATION IN EYE 2 0.0005
360 HYPERPROLACTINAEMIA 3 0.0005
361 PRURITUS GENERALISED 10 0.0005
362 PLATELET COUNT INCREASED 6 0.0005
363 LOCAL SWELLING 8 0.0005
364 MENORRHAGIA 9 0.0005
365 POLYP 3 0.0005
366 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
367 DRY MOUTH 37 0.0005
368 PULMONARY CONGESTION 6 0.0005
369 HYPERSOMNIA 13 0.0005
370 LIMB DISCOMFORT 14 0.0005
371 INTESTINAL OBSTRUCTION 17 0.0005
372 POST-TRAUMATIC STRESS DISORDER 3 0.0004
373 JOINT RANGE OF MOTION DECREASED 6 0.0004
374 FISTULA 5 0.0004
375 SINUS CONGESTION 6 0.0004
376 BONE PAIN 26 0.0004
377 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
378 PANIC ATTACK 16 0.0004
379 ECCHYMOSIS 3 0.0004
380 RIB FRACTURE 9 0.0004
381 INJECTION SITE WARMTH 9 0.0004
382 CORONARY ARTERY OCCLUSION 6 0.0004
383 RETINAL DETACHMENT 4 0.0004
384 PRODUCT QUALITY ISSUE 59 0.0004
385 HEART RATE INCREASED 43 0.0004
386 OVARIAN CANCER 4 0.0004
387 WEIGHT INCREASED 97 0.0004
388 IRRITABILITY 26 0.0004
389 FORMICATION 3 0.0004
390 EXTRASYSTOLES 3 0.0004
391 DERMATITIS 9 0.0004
392 MASS 6 0.0004
393 CARPAL TUNNEL SYNDROME 6 0.0004
394 PHOTOPHOBIA 8 0.0004
395 ANXIETY 121 0.0004
396 STAPHYLOCOCCAL INFECTION 14 0.0004
397 VENTRICULAR TACHYCARDIA 7 0.0004
398 HAND FRACTURE 3 0.0004
399 HYPOCALCAEMIA 8 0.0004
400 DEPRESSION 96 0.0004
401 OROPHARYNGEAL PAIN 39 0.0004
402 PRODUCT ADHESION ISSUE 15 0.0004
403 CATARACT 25 0.0004
404 LOWER LIMB FRACTURE 8 0.0004
405 MUSCLE SPASMS 76 0.0004
406 ANGER 14 0.0004
407 ATELECTASIS 4 0.0004
408 FAECES SOFT 3 0.0004
409 MAJOR DEPRESSION 3 0.0004
410 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
411 GASTRIC DISORDER 14 0.0004
412 FREQUENT BOWEL MOVEMENTS 11 0.0004
413 BLINDNESS TRANSIENT 3 0.0004
414 APPLICATION SITE BURN 2 0.0004
415 CEREBRAL DISORDER 3 0.0004
416 LIGAMENT SPRAIN 4 0.0004
417 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
418 EMBEDDED DEVICE 4 0.0004
419 FLUSHING 41 0.0004
420 EYE SWELLING 15 0.0004
421 BONE LOSS 6 0.0004
422 PRODUCT PHYSICAL ISSUE 8 0.0004
423 EMPHYSEMA 4 0.0004
424 CHOLELITHIASIS 13 0.0004
425 PARAESTHESIA 62 0.0004
426 VISION BLURRED 54 0.0004
427 TOOTH ABSCESS 4 0.0004
428 SUBARACHNOID HAEMORRHAGE 4 0.0004
429 DISSOCIATION 3 0.0004
430 PROCEDURAL COMPLICATION 3 0.0004
431 PRODUCT PREPARATION ERROR 8 0.0004
432 DISTURBANCE IN ATTENTION 21 0.0004
433 TEMPERATURE INTOLERANCE 4 0.0004
434 BACK PAIN 90 0.0004
435 APHTHOUS ULCER 3 0.0004
436 HIATUS HERNIA 5 0.0004
437 TREMOR 64 0.0004
438 BASAL CELL CARCINOMA 6 0.0004
439 SWOLLEN TONGUE 12 0.0004
440 MULTIPLE ALLERGIES 3 0.0004
441 RESTLESSNESS 14 0.0004
442 FOLLICULITIS 4 0.0004
443 CATATONIA 2 0.0004
444 BLOOD PRESSURE INCREASED 58 0.0004
445 RENAL PAIN 4 0.0004
446 MUSCULOSKELETAL STIFFNESS 33 0.0004
447 SCIATICA 6 0.0004
448 NIGHTMARE 13 0.0004
449 UTERINE CANCER 3 0.0004
450 ABDOMINAL DISTENSION 39 0.0004
451 INJECTION SITE PRURITUS 25 0.0004
452 QUALITY OF LIFE DECREASED 5 0.0004
453 SENSORY LOSS 3 0.0004
454 FRUSTRATION TOLERANCE DECREASED 3 0.0004
455 BRUXISM 2 0.0004
456 DECREASED ACTIVITY 4 0.0004
457 THROAT TIGHTNESS 10 0.0004
458 CHEILITIS 2 0.0004
459 BACK DISORDER 6 0.0004
460 FAECES DISCOLOURED 8 0.0004
461 POST PROCEDURAL INFECTION 3 0.0004
462 BLOOD URINE PRESENT 7 0.0004
463 HYPOKALAEMIA 17 0.0004
464 BACK INJURY 4 0.0004
465 PULMONARY THROMBOSIS 4 0.0004
466 POLYURIA 3 0.0004
467 GINGIVAL BLEEDING 5 0.0004
468 WOUND INFECTION 4 0.0004
469 BRONCHITIS 27 0.0004
470 PRODUCT SUBSTITUTION ISSUE 21 0.0004
471 POST PROCEDURAL COMPLICATION 7 0.0004
472 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
473 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
474 TOOTH DISORDER 8 0.0004
475 POLLAKIURIA 15 0.0004
476 ORAL HERPES 7 0.0004
477 OCULAR HYPERAEMIA 17 0.0004
478 CHROMATURIA 8 0.0004
479 HEART RATE IRREGULAR 8 0.0004
480 COLECTOMY 2 0.0004
481 REBOUND EFFECT 4 0.0004
482 AMNESIA 23 0.0004
483 SINUS DISORDER 7 0.0004
484 DISORIENTATION 14 0.0004
485 FLATULENCE 20 0.0004
486 IMPAIRED DRIVING ABILITY 4 0.0004
487 PARANOIA 6 0.0003
488 BLOOD MAGNESIUM DECREASED 3 0.0003
489 MUSCLE STRAIN 3 0.0003
490 CARDIAC MURMUR 3 0.0003
491 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
492 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
493 SKIN SWELLING 3 0.0003
494 ANOSMIA 5 0.0003
495 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
496 CONTUSION 33 0.0003
497 COGNITIVE DISORDER 16 0.0003
498 GASTRITIS 9 0.0003
499 ARTHROPATHY 19 0.0003
500 CHEST DISCOMFORT 35 0.0003
501 SEXUAL DYSFUNCTION 4 0.0003
502 HEAD DISCOMFORT 6 0.0003
503 SKIN HAEMORRHAGE 5 0.0003
504 EYE PAIN 19 0.0003
505 WRONG DRUG ADMINISTERED 3 0.0003
506 FACIAL PAIN 3 0.0003
507 PULMONARY MASS 5 0.0003
508 CARDIAC PACEMAKER INSERTION 2 0.0003
509 HEADACHE 210 0.0003
510 HAEMORRHAGE INTRACRANIAL 5 0.0003
511 DRUG EFFECT DECREASED 18 0.0003
512 WITHDRAWAL SYNDROME 14 0.0003
513 HYPOAESTHESIA ORAL 5 0.0003
514 LACRIMATION INCREASED 10 0.0003
515 LIP DRY 3 0.0003
516 LETHARGY 19 0.0003
517 FUNGAL INFECTION 11 0.0003
518 MOOD ALTERED 9 0.0003
519 CHRONIC KIDNEY DISEASE 25 0.0003
520 EATING DISORDER 7 0.0003
521 DRUG DISPENSING ERROR 5 0.0003
522 INJECTION SITE URTICARIA 8 0.0003
523 INCREASED TENDENCY TO BRUISE 3 0.0003
524 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
525 DYSURIA 12 0.0003
526 DYSPEPSIA 32 0.0003
527 NERVE COMPRESSION 3 0.0003
528 DIVERTICULITIS 9 0.0003
529 CHILLS 38 0.0003
530 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
531 MUSCULOSKELETAL CHEST PAIN 5 0.0003
532 PERSONALITY CHANGE 3 0.0003
533 INJECTION SITE ERYTHEMA 40 0.0003
534 HEPATIC STEATOSIS 6 0.0003
535 TOOTH EXTRACTION 4 0.0003
536 NEPHROPATHY 3 0.0003
537 ARTERIOSCLEROSIS 3 0.0003
538 BLEPHAROSPASM 2 0.0003
539 SPUTUM DISCOLOURED 3 0.0003
540 SLEEP APNOEA SYNDROME 6 0.0003
541 INJECTION SITE BRUISING 25 0.0003
542 HEART RATE DECREASED 11 0.0003
543 INTRAOCULAR PRESSURE INCREASED 4 0.0003
544 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
545 BALANCE DISORDER 27 0.0003
546 SINUSITIS 32 0.0003
547 AFFECT LABILITY 3 0.0003
548 MOVEMENT DISORDER 10 0.0003
549 GENITAL HAEMORRHAGE 4 0.0003
550 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
551 DYSGEUSIA 23 0.0003
552 MUSCLE TIGHTNESS 5 0.0003
553 HEPATIC ENZYME INCREASED 21 0.0003
554 ARTHRALGIA 128 0.0003
555 DYSPHONIA 18 0.0003
556 HAEMORRHOIDS 6 0.0003
557 NODULE 4 0.0003
558 BRADYPHRENIA 2 0.0003
559 SUICIDAL IDEATION 28 0.0003
560 KNEE OPERATION 3 0.0003
561 DIZZINESS 152 0.0003
562 IMPAIRED HEALING 10 0.0003
563 INCORRECT PRODUCT STORAGE 4 0.0003
564 TOOTH INFECTION 4 0.0003
565 PHOTOSENSITIVITY REACTION 5 0.0003
566 CONSTIPATION 66 0.0003
567 BLADDER DISORDER 3 0.0003
568 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
569 DYSMENORRHOEA 4 0.0003
570 VISUAL ACUITY REDUCED 10 0.0003
571 WEIGHT DECREASED 84 0.0003
572 EXPIRED PRODUCT ADMINISTERED 10 0.0003
573 EYE HAEMORRHAGE 4 0.0003
574 PAIN 184 0.0003
575 BREAST MASS 2 0.0003
576 PAIN OF SKIN 8 0.0003
577 DRUG DOSE OMISSION 49 0.0003
578 HYPOTHERMIA 3 0.0003
579 PRODUCT TASTE ABNORMAL 4 0.0003
580 EYE IRRITATION 17 0.0003
581 PAIN IN EXTREMITY 87 0.0003
582 RASH PRURITIC 16 0.0003
583 MYALGIA 50 0.0003
584 HYPOAESTHESIA 44 0.0003
585 METRORRHAGIA 5 0.0003
586 BLOOD TESTOSTERONE DECREASED 2 0.0003
587 SWELLING FACE 19 0.0003
588 MEMORY IMPAIRMENT 40 0.0003
589 FATIGUE 226 0.0003
590 TOOTH LOSS 6 0.0003
591 NASAL CONGESTION 17 0.0003
592 VENTRICULAR EXTRASYSTOLES 3 0.0003
593 PROCEDURAL PAIN 8 0.0003
594 PRESYNCOPE 7 0.0003
595 BONE DENSITY DECREASED 9 0.0003
596 HUNGER 4 0.0003
597 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
598 SCRATCH 3 0.0003
599 PULMONARY EMBOLISM 27 0.0003
600 INCONTINENCE 3 0.0003
601 DEPRESSED MOOD 15 0.0003
602 BLINDNESS UNILATERAL 4 0.0003
603 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
604 SINUS TACHYCARDIA 4 0.0003
605 MUSCULAR WEAKNESS 32 0.0003
606 INFLUENZA LIKE ILLNESS 23 0.0003
607 BREAST CANCER METASTATIC 3 0.0003
608 NAUSEA 221 0.0003
609 RHINORRHOEA 18 0.0003
610 BIPOLAR DISORDER 3 0.0003
611 DYSSTASIA 8 0.0003
612 PERIPHERAL SWELLING 42 0.0003
613 TOOTH FRACTURE 3 0.0003
614 DENTAL CARIES 3 0.0003
615 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
616 FOOT DEFORMITY 3 0.0003
617 CARDIOMYOPATHY 4 0.0003
618 INJECTION SITE MASS 10 0.0003
619 ARTHROPOD BITE 2 0.0003
620 SKIN DISORDER 9 0.0003
621 MALNUTRITION 3 0.0003
622 DEAFNESS 7 0.0003
623 SKIN INFECTION 3 0.0003
624 OCULAR DISCOMFORT 3 0.0003
625 SPEECH DISORDER 14 0.0003
626 BLISTER 15 0.0003
627 MITRAL VALVE INCOMPETENCE 3 0.0003
628 APPLICATION SITE PRURITUS 6 0.0003
629 BLOOD COUNT ABNORMAL 4 0.0003
630 URINARY TRACT INFECTION 45 0.0003
631 DERMATITIS CONTACT 3 0.0003
632 ROAD TRAFFIC ACCIDENT 11 0.0003
633 INTENTIONAL PRODUCT MISUSE 23 0.0003
634 VERTIGO 16 0.0003
635 ABDOMINAL DISCOMFORT 44 0.0003
636 CONVULSION 15 0.0003
637 ABDOMINAL PAIN 61 0.0003
638 INCREASED APPETITE 5 0.0003
639 BOWEL MOVEMENT IRREGULARITY 2 0.0003
640 SKIN DISCOLOURATION 12 0.0003
641 ATRIOVENTRICULAR BLOCK 2 0.0003
642 ASTHENIA 97 0.0003
643 VASCULITIS 3 0.0003
644 LUNG INFECTION 4 0.0003
645 EAR PAIN 5 0.0003
646 BURNING SENSATION 18 0.0003
647 SWELLING 24 0.0003
648 CHOKING 5 0.0003
649 HAEMATOCHEZIA 14 0.0003
650 BLOOD IRON DECREASED 3 0.0003
651 ABDOMINAL PAIN UPPER 52 0.0003
652 PNEUMOTHORAX 4 0.0003
653 HAEMATOCRIT DECREASED 5 0.0003
654 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
655 OBESITY 4 0.0003
656 INJECTION SITE PAIN 77 0.0003
657 MOBILITY DECREASED 18 0.0003
658 INCORRECT DOSE ADMINISTERED 57 0.0002
659 FALL 83 0.0002
660 HIP FRACTURE 8 0.0002
661 HEPATITIS C 3 0.0002
662 CHEST PAIN 46 0.0002
663 SOMNOLENCE 50 0.0002
664 DRUG EFFECT INCOMPLETE 9 0.0002
665 MENTAL IMPAIRMENT 6 0.0002
666 PRODUCT ADMINISTRATION ERROR 5 0.0002
667 ADRENAL INSUFFICIENCY 3 0.0002
668 PSORIATIC ARTHROPATHY 10 0.0002
669 DYSKINESIA 10 0.0002
670 NO THERAPEUTIC RESPONSE 3 0.0002
671 LIVER INJURY 6 0.0002
672 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
673 CARDIOMEGALY 3 0.0002
674 SPINAL OPERATION 3 0.0002
675 EYE DISORDER 8 0.0002
676 GENERALISED OEDEMA 3 0.0002
677 DYSPHAGIA 23 0.0002
678 CONFUSIONAL STATE 39 0.0002
679 APPLICATION SITE IRRITATION 3 0.0002
680 GAIT DISTURBANCE 46 0.0002
681 COAGULOPATHY 4 0.0002
682 PRODUCT USE ISSUE 45 0.0002
683 MALAISE 105 0.0002
684 BLOOD UREA INCREASED 4 0.0002
685 SURGERY 14 0.0002
686 UNEVALUABLE EVENT 18 0.0002
687 INJECTION SITE HAEMORRHAGE 19 0.0002
688 ACNE 18 0.0002
689 SKIN BURNING SENSATION 17 0.0002
690 ABDOMINAL PAIN LOWER 6 0.0002
691 CANDIDA INFECTION 4 0.0002
692 CARDIOVASCULAR DISORDER 6 0.0002
693 FLUID RETENTION 12 0.0002
694 RENAL INJURY 7 0.0002
695 INJECTION SITE SWELLING 18 0.0002
696 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
697 URTICARIA 39 0.0002
698 DEHYDRATION 31 0.0002
699 HYPOACUSIS 10 0.0002
700 JOINT SWELLING 28 0.0002
701 AGITATION 17 0.0002
702 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
703 DEEP VEIN THROMBOSIS 15 0.0002
704 SYNCOPE 23 0.0002
705 MENTAL DISORDER 10 0.0002
706 PRODUCT DOSE OMISSION 15 0.0002
707 RASH MACULAR 8 0.0002
708 JOINT STIFFNESS 6 0.0002
709 BEDRIDDEN 3 0.0002
710 INJECTION SITE RASH 7 0.0002
711 DRUG WITHDRAWAL SYNDROME 20 0.0002
712 COLD SWEAT 4 0.0002
713 HERPES ZOSTER 13 0.0002
714 EAR INFECTION 6 0.0002
715 MALIGNANT MELANOMA 3 0.0002
716 THIRST 4 0.0002
717 ORAL PAIN 5 0.0002
718 GOUT 4 0.0002
719 PANCREATITIS ACUTE 5 0.0002
720 HYPERTENSION 47 0.0002
721 DIARRHOEA 143 0.0002
722 OEDEMA 12 0.0002
723 VOMITING 104 0.0002
724 COUGH 62 0.0002
725 LIMB INJURY 6 0.0002
726 IMPAIRED GASTRIC EMPTYING 3 0.0002
727 END STAGE RENAL DISEASE 4 0.0002
728 DYSPNOEA 124 0.0002
729 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
730 NEPHROLITHIASIS 10 0.0002
731 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
732 MUSCLE TWITCHING 5 0.0002
733 ORAL DISCOMFORT 3 0.0002
734 CONJUNCTIVITIS 4 0.0002
735 APPENDICITIS 2 0.0002
736 BLOOD TEST ABNORMAL 3 0.0002
737 PRURITUS 82 0.0002
738 INFLAMMATION 11 0.0002
739 TARDIVE DYSKINESIA 6 0.0002
740 DYSARTHRIA 8 0.0002
741 DYSPNOEA EXERTIONAL 8 0.0002
742 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 43 0.0002
743 FRACTURE 4 0.0002
744 LOSS OF CONSCIOUSNESS 27 0.0002
745 GASTRIC ULCER 4 0.0002
746 MUSCULOSKELETAL DISORDER 4 0.0002
747 GAIT INABILITY 7 0.0002
748 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
749 BLOOD PRESSURE FLUCTUATION 5 0.0002
750 DRUG PRESCRIBING ERROR 4 0.0002
751 GLAUCOMA 4 0.0002
752 PRESCRIBED OVERDOSE 4 0.0002
753 DYSTONIA 4 0.0002
754 NEURALGIA 5 0.0002
755 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
756 OEDEMA PERIPHERAL 25 0.0002
757 SKIN FISSURES 4 0.0002
758 ASCITES 6 0.0002
759 INJECTION SITE REACTION 14 0.0002
760 ABNORMAL BEHAVIOUR 8 0.0002
761 COLITIS ULCERATIVE 9 0.0002
762 NASOPHARYNGITIS 37 0.0002
763 EPISTAXIS 15 0.0002
764 AGEUSIA 5 0.0002
765 SPINAL FRACTURE 4 0.0002
766 BRAIN INJURY 2 0.0002
767 SLEEP DISORDER 14 0.0002
768 MEDICATION ERROR 11 0.0002
769 DRUG INEFFECTIVE 260 0.0002
770 INFLUENZA 22 0.0002
771 HIP ARTHROPLASTY 3 0.0002
772 DRUG ADMINISTRATION ERROR 6 0.0002
773 HYPERSENSITIVITY 36 0.0002
774 ANAPHYLACTIC SHOCK 5 0.0002
775 DECREASED APPETITE 45 0.0002
776 FEMUR FRACTURE 6 0.0002
777 HAEMATOMA 5 0.0002
778 CONDITION AGGRAVATED 58 0.0002
779 GASTROINTESTINAL DISORDER 17 0.0002
780 HEAD INJURY 6 0.0002
781 DISEASE RECURRENCE 9 0.0002
782 RESPIRATORY TRACT CONGESTION 3 0.0002
783 ULCER 3 0.0002
784 PRODUCTIVE COUGH 9 0.0002
785 PYREXIA 65 0.0002
786 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
787 LIVER FUNCTION TEST INCREASED 4 0.0002
788 RECTAL HAEMORRHAGE 8 0.0002
789 JAUNDICE 5 0.0002
790 SKIN CANCER 4 0.0002
791 BLOOD BILIRUBIN INCREASED 5 0.0002
792 INJURY 13 0.0002
793 BLOOD POTASSIUM INCREASED 3 0.0002
794 RASH 80 0.0002
795 ACUTE KIDNEY INJURY 28 0.0002
796 METASTASES TO BONE 3 0.0002
797 ASPIRATION 2 0.0002
798 MANIA 3 0.0002
799 EMOTIONAL DISTRESS 22 0.0002
800 RENAL FAILURE 24 0.0002
801 BLOOD PRESSURE DECREASED 12 0.0002
802 LIP SWELLING 6 0.0002
803 OFF LABEL USE 157 0.0002
804 NEUROPATHY PERIPHERAL 17 0.0002
805 DEVICE ISSUE 16 0.0002
806 SNEEZING 4 0.0002
807 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
808 THROAT IRRITATION 8 0.0002
809 ADVERSE DRUG REACTION 16 0.0002
810 VISUAL IMPAIRMENT 22 0.0002
811 RHEUMATOID ARTHRITIS 20 0.0002
812 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
813 RED BLOOD CELL COUNT DECREASED 5 0.0002
814 THROMBOSIS 14 0.0002
815 DRY SKIN 23 0.0002
816 MYOCARDIAL INFARCTION 30 0.0002
817 SYRINGE ISSUE 3 0.0002
818 AMENORRHOEA 3 0.0002
819 CARDIAC DISORDER 16 0.0002
820 ACUTE MYOCARDIAL INFARCTION 5 0.0002
821 LABORATORY TEST ABNORMAL 5 0.0002
822 ISCHAEMIC STROKE 3 0.0002
823 ACCIDENT 2 0.0002
824 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
825 SYNOVITIS 3 0.0002
826 BLOOD POTASSIUM DECREASED 5 0.0002
827 GASTROENTERITIS VIRAL 3 0.0002
828 SKIN EXFOLIATION 14 0.0002
829 OSTEOMYELITIS 3 0.0002
830 APHASIA 5 0.0002
831 THERAPEUTIC RESPONSE DECREASED 10 0.0002
832 TREATMENT NONCOMPLIANCE 9 0.0002
833 UNDERDOSE 12 0.0002
834 PLEURAL EFFUSION 10 0.0002
835 DISCOMFORT 10 0.0002
836 ABASIA 4 0.0002
837 DEVICE DISLOCATION 7 0.0002
838 BACTERIAL INFECTION 3 0.0002
839 HEPATIC CIRRHOSIS 3 0.0002
840 BLOOD SODIUM DECREASED 3 0.0002
841 HAEMATEMESIS 4 0.0002
842 OVERDOSE 34 0.0002
843 HYPOPHAGIA 4 0.0002
844 ANOREXIA 2 0.0002
845 HERNIA 3 0.0002
846 DIPLOPIA 4 0.0002
847 BLOOD CREATININE INCREASED 10 0.0002
848 PSORIASIS 20 0.0002
849 SKIN IRRITATION 7 0.0002
850 ANHEDONIA 4 0.0002
851 WHEEZING 9 0.0002
852 DRUG INTERACTION 24 0.0002
853 BLOOD PRESSURE ABNORMAL 3 0.0002
854 ERYTHEMA 31 0.0002
855 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
856 VIRAL INFECTION 5 0.0002
857 RENAL DISORDER 7 0.0002
858 PREGNANCY 3 0.0001
859 TYPE 2 DIABETES MELLITUS 5 0.0001
860 FEEDING DISORDER 3 0.0001
861 CEREBROVASCULAR ACCIDENT 25 0.0001
862 INJURY ASSOCIATED WITH DEVICE 3 0.0001
863 BODY TEMPERATURE INCREASED 3 0.0001
864 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
865 AKATHISIA 2 0.0001
866 SKIN LESION 4 0.0001
867 HYPOGLYCAEMIA 7 0.0001
868 DIABETES MELLITUS 11 0.0001
869 DELIRIUM 5 0.0001
870 MENTAL STATUS CHANGES 4 0.0001
871 ATRIAL FIBRILLATION 14 0.0001
872 KNEE ARTHROPLASTY 3 0.0001
873 MOUTH ULCERATION 3 0.0001
874 DEVICE MALFUNCTION 10 0.0001
875 ADVERSE EVENT 13 0.0001
876 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
877 ANGINA PECTORIS 4 0.0001
878 CARDIAC FAILURE CONGESTIVE 11 0.0001
879 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
880 GLOSSODYNIA 3 0.0001
881 ECZEMA 7 0.0001
882 RESPIRATORY DISORDER 4 0.0001
883 ASTHMA 15 0.0001
884 PANCREATITIS 7 0.0001
885 CORONARY ARTERY DISEASE 4 0.0001
886 ILL-DEFINED DISORDER 8 0.0001
887 INFECTION 19 0.0001
888 NERVOUS SYSTEM DISORDER 4 0.0001
889 ANAPHYLACTIC REACTION 7 0.0001
890 PRODUCT PRESCRIBING ERROR 3 0.0001
891 RASH ERYTHEMATOUS 6 0.0001
892 MULTIPLE SCLEROSIS 6 0.0001
893 ABSCESS 2 0.0001
894 HEPATIC CANCER 3 0.0001
895 HYPOTENSION 25 0.0001
896 OXYGEN SATURATION DECREASED 7 0.0001
897 HAEMORRHAGE 13 0.0001
898 HYPONATRAEMIA 7 0.0001
899 LOCALISED INFECTION 3 0.0001
900 EXTRA DOSE ADMINISTERED 5 0.0001
901 LUNG DISORDER 6 0.0001
902 LUNG NEOPLASM MALIGNANT 5 0.0001
903 SEIZURE 14 0.0001
904 INFUSION RELATED REACTION 8 0.0001
905 PNEUMONIA ASPIRATION 3 0.0001
906 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
907 AGGRESSION 6 0.0001
908 HALLUCINATION 9 0.0001
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
910 THERAPY CESSATION 6 0.0001
911 HAEMATURIA 4 0.0001
912 DRUG RESISTANCE 3 0.0001
913 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
914 SKIN ULCER 3 0.0001
915 RASH GENERALISED 3 0.0001
916 STOMATITIS 7 0.0001
917 RESPIRATORY TRACT INFECTION 3 0.0001
918 SEDATION 3 0.0001
919 HYPOXIA 4 0.0001
920 EXPOSURE DURING PREGNANCY 7 0.0001
921 PULMONARY OEDEMA 5 0.0001
922 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
923 HAEMOPTYSIS 3 0.0001
924 PANCYTOPENIA 6 0.0001
925 WOUND 3 0.0001
926 HAEMOGLOBIN DECREASED 11 0.0001
927 ARRHYTHMIA 5 0.0001
928 COLITIS 4 0.0001
929 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
930 PLATELET COUNT DECREASED 11 0.0001
931 LIVER FUNCTION TEST ABNORMAL 3 0.0001
932 NEEDLE ISSUE 3 0.0001
933 PLASMA CELL MYELOMA 4 0.0001
934 TACHYCARDIA 9 0.0001
935 BLOOD GLUCOSE INCREASED 19 0.0001
936 COMPLICATION OF DEVICE INSERTION 2 0.0001
937 ABORTION SPONTANEOUS 4 0.0001
938 ANAEMIA 19 0.0001
939 CELLULITIS 5 0.0001
940 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
941 PNEUMONIA 32 0.0001
942 BLINDNESS 4 0.0001
943 GYNAECOMASTIA 3 0.0001
944 CARDIAC ARREST 8 0.0001
945 COMPLETED SUICIDE 8 0.0001
946 DRUG-INDUCED LIVER INJURY 3 0.0001
947 BRADYCARDIA 5 0.0001
948 RENAL FAILURE ACUTE 4 0.0001
949 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
950 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
951 LIVER DISORDER 4 0.0001
952 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
953 EYE PRURITUS 3 0.0001
954 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
955 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
956 COMA 4 0.0001
957 RENAL IMPAIRMENT 7 0.0001
958 DRUG INTOLERANCE 8 0.0001
959 HYPERGLYCAEMIA 3 0.0001
960 PRODUCT STORAGE ERROR 7 0.0001
961 NO ADVERSE EVENT 14 0.0001
962 DISEASE PROGRESSION 9 0.0001
963 NEUTROPHIL COUNT DECREASED 3 0.0001
964 RHABDOMYOLYSIS 3 0.0001
965 CARDIO-RESPIRATORY ARREST 3 0.0001
966 DEVICE LEAKAGE 3 0.0001
967 SEPTIC SHOCK 3 0.0001
968 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
969 RESPIRATORY FAILURE 5 0.0001
970 ILLNESS 7 0.0001
971 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
972 SUICIDE ATTEMPT 4 0.0001
973 BLOOD GLUCOSE DECREASED 3 0.0001
974 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
976 HOSPITALISATION 9 0.0001
977 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
978 ACCIDENTAL OVERDOSE 2 0.0001
979 SEPSIS 6 0.0001
980 CARDIAC FAILURE 4 0.0000
981 ANGIOEDEMA 2 0.0000
982 NEOPLASM MALIGNANT 3 0.0000
983 PRODUCT DOSE OMISSION ISSUE 13 0.0000
984 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
985 DRUG DEPENDENCE 6 0.0000
986 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
987 TOXICITY TO VARIOUS AGENTS 6 0.0000
988 COVID-19 6 0.0000
989 DEATH 28 0.0000
990 NEUTROPENIA 3 0.0000